Co-Authors
This is a "connection" page, showing publications co-authored by Edoardo Savarino and Andrea Buda.
Connection Strength
1.124
-
Starting a Biologic Therapy in IBD Patients Amid COVID-19: Hold, Careful Monitoring, or Testing? J Crohns Colitis. 2020 12 02; 14(12):1785.
Score: 0.229
-
Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice. Dig Liver Dis. 2020 11; 52(11):1252-1253.
Score: 0.227
-
Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment? Gastroenterology. 2021 06; 160(7):2626-2627.
Score: 0.225
-
Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nocere. Dig Liver Dis. 2020 11; 52(11):1248-1249.
Score: 0.224
-
Screening for active COVID-19 infection and immunization status prior to biologic therapy in IBD patients at the time of the pandemic outbreak. Dig Liver Dis. 2020 06; 52(6):604-605.
Score: 0.219